摘要

Objectives: Regenerative medicine is revolutionizing cosmetic surgery—from scarless healing and improved fat graft survival to enhanced outcomes in facial rejuvenation, body contouring, and hair restoration. Welcome to cosmetic surgery 3.0. This session reviews how biologics like PRP, SVF, exosomes, and peptides are being integrated into surgical workflows to optimize healing, stimulate collagen, and extend aesthetic results, offering a bridge between traditional surgery and next-generation aesthetic medicine. Introduction: Cosmetic surgery is evolving from structural manipulation toward biologically based restoration. Regenerative medicine introduces tools that stimulate natural healing, modulate inflammation, and regenerate tissue. This presentation introduces “Cosmetic Surgery 3.0”—a new paradigm where cellular therapies and biologics complement traditional surgery to achieve better, longer-lasting aesthetic results. Materials / method: This review draws on clinical experience, published trials, and case studies involving biologics used in facial surgery, fat grafting, body contouring, and hair restoration. Protocols include intraoperative use of SVF-enriched fat, PRP injections post-rhytidectomy, and peptides for enhanced recovery. Techniques for biologic delivery, combination therapy, and timing across pre-, intra-, and post-op phases are discussed. Results: Clinical integration of biologics shows improved healing times, reduced postoperative inflammation, enhanced graft retention, and superior skin texture and tone. In facelift patients, PRP and peptide adjuncts reduced scarring and downtime. SVF-enriched grafts demonstrated higher volume retention in facial and gluteal procedures. Hair restoration cases showed improved density and donor preservation. Conclusion: Regenerative therapies are redefining aesthetic outcomes. Biologics like PRP, SVF, exosomes, and peptides not only enhance healing but elevate long-term aesthetic results. Surgeons who adopt these tools can offer next-generation outcomes with less morbidity. As evidence grows, regenerative protocols will likely become standard in facial and body cosmetic surgery workflows